AR054804A1 - Derivados de quinolina, composicion farmaceutica que los comprende y su uso en combinacion con otros agentes antibacterianos para el tratamiento de infecciones bacterianas - Google Patents
Derivados de quinolina, composicion farmaceutica que los comprende y su uso en combinacion con otros agentes antibacterianos para el tratamiento de infecciones bacterianasInfo
- Publication number
- AR054804A1 AR054804A1 ARP060102758A ARP060102758A AR054804A1 AR 054804 A1 AR054804 A1 AR 054804A1 AR P060102758 A ARP060102758 A AR P060102758A AR P060102758 A ARP060102758 A AR P060102758A AR 054804 A1 AR054804 A1 AR 054804A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- carbon atoms
- alkyloxy
- saturated hydrocarbon
- group
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/36—Sulfur atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Quinoline Compounds (AREA)
Abstract
El uso de un compuesto para la fabricacion de un medicamento para el tratamiento de una infeccion bacteriana siempre y cuando la infeccion bacteriana no sea una infeccion Micobacteriana, un compuesto de formula (1 a) o (1b). Reivindicacion 1: El uso de un compuesto para la fabricacion de un medicamento para el tratamiento de una infeccion bacteriana, siendo dicho compuesto un compuesto de la formula (1 a) o (1b), un N-oxido del mismo, una forma tautomérica del mismo o una forma estereoquímicamente isomérica del mismo donde A es un counterion farmacéuticamente aceptable; R1 es hidrogeno, halo, haloalquilo, ciano, hidroxi, Ar, Het, alquilo, alquiloxi, alquiltio, alquiloxialquilo, alquiltioalquilo, Ar-alquilo o di(Ar)alquilo; p es un numero entero igual a 1, 2, 3 o 4; R2 es hidrogeno, hidroxi, mercapto, alquiloxi, alquiloxialquiloxi, alquiltio, mono o di(alquil)amino o un radical de formula (3) donde Y es CH2, O, S, NH o N-alquilo; R3 es alquilo, Ar, Ar-alquilo, Het o Het-alquilo; q es un numero entro igual a cero, 1, 2, 3 o 4; R4 y R5 son cada uno independientemente hidrogeno, alquilo o bencilo; R4 y R5 juntos e incluyendo el N al que están ligados pueden formar un radical seleccionado del grupo formado por pirrolidinilo, 2-pirrolinilo, 3-pirrolinilo, pirrolilo, imidazolidinilo, pirazolidinilo, 2-imidazolinilo, 2-pirazolinilo, imidazolilo, pirazolilo, triazolilo, piperidinilo, piridinilo, piperazinilo, piridazinilo, pirimidinilo, pirazinilo, triazinilo, morfolinilo y tiomorfolinilo, pudiendo estar cada uno de dichos anillos opcionalmente sustituido con alquilo, halo, haloalquilo, hidroxi, alquiloxi, amino, mono o di-alquilamino, alquiltio, alquiloxialquilo, alquiltioalquilo, Ar-alquilo o pirimidinilo; R6 es hidrogeno, halo haloalquilo, hidroxi, Ar, alquilo, alquiloxi, alquiltio, alquiloxialquilo, alquiltioalquilo, Ar-alquilo o di(Ar)alquilo; o dos radicales R6 vecinos pueden tomarse en conjunto para formar un radical bivalente de formula -CH=CH-CH=CH-; r es un numero entero igual a 1, 2, 3, 4 o 5; R7 es hidrogeno, alquilo, Ar o Het; R8 es hidrogeno o alquilo; R9 es oxo; o R8 y R9 juntos forman el radical -CH=CH-N; R10 es alquilo, alquilcarbonilo, Ar, Ar-alquilo, Ar- carbonilo, Het1-alquilo o Het1-carbonilo; ôalquiloö es un radical hidrocarburo saturado recto o ramificado que tiene de 1 a 6 átomos de carbono; o es un radical hidrocarburo saturado cíclico que tiene de 3 a 6 átomos de carbono; o es un radical hidrocarburo saturado cíclico que tiene de 3 a 6 átomos de carbono ligados a un radical hidrocarburo saturado recto o ramificado que tiene de 1 a 6 átomos de carbono; donde cada átomo de carbono puede estar opcionalmente sustituido con hidroxi, alquiloxi u oxo; ?Ar! Es un homociclo seleccionado del grupo formado por fenilo, naftilo, acenaftilo, tetrahidronaftilo, cada homociclo opcionalmente sustituido con 1, 2 o 3 sustituyentes, cada sustituyente independientemente seleccionado del grupo formado por hidroxi, halo, ciano, nitro, amino, mono-o dialquilamino, alquilo, haloalquilo, alquiloxi, haloalquiloxi, carboxilo, alquiloxicarbonilo, aminocarbonilo, morfolinilo y mono-o dialquilaminocarbonilo; ôHetö Es un heterociclo monocíclico seleccionado del grupo formado por N-fenoxipiperidinilo, piperidinilo, pirrolilo, pirazolilo, imidazolilo, furanilo, tienilo, oxazolilo, isoxazolilo, tiazolilo, isotiazolilo, piridinilo, pirimidinilo, pirazinilo y piridazinilo; o un heterociclo bicíclico seleccionado del grupo formado por quinolinilo, quinoxalinilo, indolilo, bencimidazolilo, benzoxazolilo, benzisoxazolilo, benzotiazolilo, benzisotiazolilo, benzofuranilo, benzotienilo, 2,3-dihidrobenzo[1,4]dioxinilo y benzo[1,3]dioxolilo; cada heterociclo monocíclico y bicíclico puede estar opcionalmente sustituido con 1, 2 o 3 sustituyentes, cada sustituyente independientemente seleccionado del grupo formado por halo, hidroxi, alquilo, alquiloxi, y Ar carbonilo; ôHetö es un heterociclo monocíclico seleccionado entre furanilo o tienilo; o un heterociclo bicíclico seleccionado entre benzofuranilo o benzotienilo; cada heterociclo monocíclico y bicíclico puede estar opcionalmente sustituido con 1, 2 o 3 sustituyentes, cada sustituyente independientemente seleccionado del grupo formado por halo, alquilo y Ar; ôhaloö es un sustituyente seleccionado del grupo formado por fluor, cloro, bromo y yodo; y haloalquilo es un radical hidrocarburo saturado recto o ramificado que tiene de 1 a 6 átomos de carbono o un radical hidrocarburo saturado cíclico que tiene de 3 a 6 átomos de carbono o un radical hidrocarburo saturado cíclico que tiene de 3 a 6 átomos de carbono ligados a un radical hidrocarburo saturado recto o ramificado que tiene de 1 a 6 átomos de carbono; donde uno o más átomos de carbono están sustituidos con uno o más átomos de halo; siempre y cuando la infeccion bactriana no sea una infeccion micobacteriana
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05105755 | 2005-06-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR054804A1 true AR054804A1 (es) | 2007-07-18 |
Family
ID=35447198
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP060102758A AR054804A1 (es) | 2005-06-28 | 2006-06-27 | Derivados de quinolina, composicion farmaceutica que los comprende y su uso en combinacion con otros agentes antibacterianos para el tratamiento de infecciones bacterianas |
Country Status (32)
Country | Link |
---|---|
US (1) | US20130030016A1 (es) |
EP (1) | EP1898909B1 (es) |
JP (1) | JP5193857B2 (es) |
KR (1) | KR101329587B1 (es) |
CN (1) | CN101252927B (es) |
AP (1) | AP2547A (es) |
AR (1) | AR054804A1 (es) |
AU (1) | AU2006263882B2 (es) |
BR (1) | BRPI0613999B8 (es) |
CA (1) | CA2612614C (es) |
CY (1) | CY1119402T1 (es) |
DK (1) | DK1898909T3 (es) |
EA (1) | EA014431B1 (es) |
ES (1) | ES2610472T3 (es) |
HK (1) | HK1120732A1 (es) |
HR (1) | HRP20170044T1 (es) |
HU (1) | HUE030264T2 (es) |
IL (1) | IL188395A (es) |
JO (1) | JO3322B1 (es) |
LT (1) | LT1898909T (es) |
MX (1) | MX2008000079A (es) |
MY (1) | MY173664A (es) |
NO (1) | NO341285B1 (es) |
NZ (1) | NZ564340A (es) |
PL (1) | PL1898909T3 (es) |
PT (1) | PT1898909T (es) |
RS (1) | RS55601B1 (es) |
SG (1) | SG166798A1 (es) |
TW (1) | TWI413520B (es) |
UA (1) | UA88701C2 (es) |
WO (1) | WO2007000434A1 (es) |
ZA (1) | ZA200711148B (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JO2752B1 (en) | 2005-06-28 | 2014-03-15 | شركة جانسين فارماسوتيكا ان. في | Quinoline derivatives acting as antibacterial agents |
JO2970B1 (en) | 2006-12-06 | 2016-03-15 | جانسين فارماسوتيكا ان. في | Quinoline antibacterial derivatives |
JO2683B1 (en) * | 2006-12-06 | 2013-03-03 | جانسين فارماسوتيكا ان. في | Quinoline antibacterial derivatives |
JP5397881B2 (ja) * | 2008-09-04 | 2014-01-22 | 昇一 城武 | グラム陽性細菌用抗菌剤及び抗菌活性増強剤 |
DK2841425T3 (en) | 2012-04-27 | 2016-06-27 | Janssen Pharmaceutica Nv | ANTIBACTERIAL QUINOLIN DERIVATIVES |
JP6153603B2 (ja) | 2012-04-27 | 2017-06-28 | ヤンセン ファーマシューティカ エヌ.ベー. | 抗菌性キノリン誘導体 |
JP7514763B2 (ja) * | 2017-10-13 | 2024-07-11 | ザ ユニバーシティー オブ クイーンズランド | 亜鉛イオノフォアおよびその使用 |
CN110606825A (zh) * | 2019-10-30 | 2019-12-24 | 成都海杰亚医药科技有限公司 | 一种制备吡啶-2-硫醇的方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6103905A (en) * | 1997-06-19 | 2000-08-15 | Sepracor, Inc. | Quinoline-indole antimicrobial agents, uses and compositions related thereto |
SI2301544T1 (sl) * | 2002-07-25 | 2013-01-31 | Janssen Pharmaceutica, N.V. | Derivati kinolina kot vmesne spojine za mikobakterijske inhibitorje |
EP1753427B1 (en) * | 2004-05-28 | 2008-04-02 | Janssen Pharmaceutica N.V. | Use of substituted quinoline derivatives for the treatment of drug resistant mycobacterial diseases |
EE05394B1 (et) * | 2004-12-24 | 2011-04-15 | Janssen Pharmaceutica N.V. | Kinoliinihendid kasutamiseks latentse tuberkuloosi ravis |
EE05697B1 (et) * | 2005-06-08 | 2014-02-17 | Janssen Pharmaceutica N.V. | Kinoliini derivaadid kui antibakteriaalsed toimeained |
-
2006
- 2006-06-26 SG SG201007976-2A patent/SG166798A1/en unknown
- 2006-06-26 KR KR1020087002246A patent/KR101329587B1/ko active IP Right Grant
- 2006-06-26 PL PL06763888T patent/PL1898909T3/pl unknown
- 2006-06-26 BR BRPI0613999A patent/BRPI0613999B8/pt not_active IP Right Cessation
- 2006-06-26 LT LTEP06763888.2T patent/LT1898909T/lt unknown
- 2006-06-26 EA EA200800151A patent/EA014431B1/ru unknown
- 2006-06-26 CA CA2612614A patent/CA2612614C/en active Active
- 2006-06-26 ES ES06763888.2T patent/ES2610472T3/es active Active
- 2006-06-26 NZ NZ564340A patent/NZ564340A/en not_active IP Right Cessation
- 2006-06-26 JP JP2008518809A patent/JP5193857B2/ja not_active Expired - Fee Related
- 2006-06-26 HU HUE06763888A patent/HUE030264T2/en unknown
- 2006-06-26 MY MYPI20063021A patent/MY173664A/en unknown
- 2006-06-26 UA UAA200714928A patent/UA88701C2/ru unknown
- 2006-06-26 AU AU2006263882A patent/AU2006263882B2/en not_active Ceased
- 2006-06-26 PT PT67638882T patent/PT1898909T/pt unknown
- 2006-06-26 RS RS20170045A patent/RS55601B1/sr unknown
- 2006-06-26 EP EP06763888.2A patent/EP1898909B1/en active Active
- 2006-06-26 CN CN200680031302.9A patent/CN101252927B/zh active Active
- 2006-06-26 AP AP2008004298A patent/AP2547A/xx active
- 2006-06-26 DK DK06763888.2T patent/DK1898909T3/en active
- 2006-06-26 WO PCT/EP2006/063552 patent/WO2007000434A1/en active Application Filing
- 2006-06-26 MX MX2008000079A patent/MX2008000079A/es active IP Right Grant
- 2006-06-27 AR ARP060102758A patent/AR054804A1/es unknown
- 2006-06-27 TW TW095123049A patent/TWI413520B/zh not_active IP Right Cessation
- 2006-06-29 JO JOP/2006/0183A patent/JO3322B1/ar active
-
2007
- 2007-12-20 ZA ZA2007/11148A patent/ZA200711148B/en unknown
- 2007-12-25 IL IL188395A patent/IL188395A/en active IP Right Grant
-
2008
- 2008-01-28 NO NO20080499A patent/NO341285B1/no not_active IP Right Cessation
- 2008-11-17 HK HK08112566.1A patent/HK1120732A1/xx not_active IP Right Cessation
-
2012
- 2012-08-07 US US13/568,569 patent/US20130030016A1/en not_active Abandoned
-
2017
- 2017-01-11 HR HRP20170044TT patent/HRP20170044T1/hr unknown
- 2017-01-18 CY CY20171100071T patent/CY1119402T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR049127A1 (es) | Uso de derivados quinolina sustituidos para el tratamiento de enfermedades micobacterianas resistentes a los farmacos | |
AR051790A1 (es) | Tratamiento de tuberculosis latente | |
AR054804A1 (es) | Derivados de quinolina, composicion farmaceutica que los comprende y su uso en combinacion con otros agentes antibacterianos para el tratamiento de infecciones bacterianas | |
AR054889A1 (es) | Derivados de quinolina como agentes bacterianos | |
AR040673A1 (es) | Inhibidores micobacterianos, composicion farmaceutica y proceso de preparacion del compuesto | |
AR064151A1 (es) | Derivados de quinolina antibacterianos, composiciones farmaceuticas que los contienen y metodo de preparacion. | |
DOP2018000187A (es) | Derivados de pirazolo[1,5-a]pirazin-4-ilo | |
EA200900155A1 (ru) | Модуляторы фармакокинетических свойств лекарственных средств | |
RU2487124C2 (ru) | Новое амидное производное и его использование в качестве лекарственного средства | |
TR201906123T4 (tr) | P13 kinazı ve mtor inhibitörleri olarak triazin bileşikleri. | |
RS20050522A (en) | Protein kinase inhibiting tricyclic compounds that increase the effects of anti-neoplastic agents and therapeutic radiation | |
ATE360631T1 (de) | Azabicyclische heterocyclen als modulatoren des cannabinoidrezeptors | |
SG149033A1 (en) | Heterocyclic inhibitors of mek and methods of use thereof | |
MX2009003157A (es) | Pirazoliltienopiridinas terapeuticas. | |
AR073740A1 (es) | Compuestos para el tratamiento de la hepatitis c | |
CA2553269A1 (en) | Quinoline derivatives and use thereof as mycobacterial inhibitors | |
AR064153A1 (es) | Derivados de quinolina antibacterianos. procesos de obtencion y composiciones farmaceuticas. | |
EA200901241A1 (ru) | Соединения для лечения гепатита с | |
MA34604B1 (fr) | Derives de la pyrazine en tant que bloqueurs de l'enac | |
AR054587A1 (es) | Derivados de quinolina antibacterianos | |
EA200800508A1 (ru) | Производные хинолина в качестве антибактериальных средств | |
FI3546462T3 (fi) | Uusi oksoisokinoliinijohdannainen | |
AR094496A1 (es) | Compuestos tetracíclicos sustituidos con heterociclo y métodos de uso de los mismos para el tratamiento de enfermedades víricas | |
AR051989A1 (es) | Derivados de quinolina como agentes antibacterianos | |
AR054626A1 (es) | Derivados de quinolina como agentes antibacterianos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |